Skip to main content

2015-01 A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia

A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia

Associated Conditions

Liver Cancer

Principal Investigator

Sponsor

AdventHealth Orlando

[Shell Only]-HUD/CUD.

This study is currently enrolling.